Publications by authors named "Dimitrios Pappas"

Claim this Profile
D
Development and External Validation of a Multivariable Predictive Model for Progression to Difficult-to-Treat Rheumatoid Arthritis in Biologic-Experienced Patients.
Misti L Paudel, Nancy Shadick, Michael Weinblatt, George Reed, Heather J Litman, Dimitrios A Pappas

Arthritis Care Res (Hoboken)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis.
Joshua F Baker, George Reed, Ted R Mikuls, Geoffrey M Thiele, Dimitrios A Pappas

Arthritis Rheumatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New onset work disability in rheumatoid arthritis is an underrecognized cardiovascular risk factor: A retrospective cohort study using the CorEvitas registry.
Robert Spandorfer, Kevin Kane, Dimitrios A Pappas, Joel Kremer, George Reed

Semin Arthritis Rheum· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients.
Dimitrios A Pappas, George Reed, Kevin Kane, Jeffrey R Curtis, Christina Charles-Schoeman

Semin Arthritis Rheum· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins.
Amir A Razmjou, Joel M Kremer, Dimitrios A Pappas, Jeffrey R Curtis, Jennifer Wang

RMD Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Fibromyalgia and Widespread Pain in Psoriatic Arthritis: Association With Disease Severity Assessment in a Large US Registry.
Philip Mease, George Reed, Alexis Ogdie, Dimitrios A Pappas, Joel M Kremer

Arthritis Care Res (Hoboken)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results From the CorEvitas Rheumatoid Arthritis Registry.
Dimitrios A Pappas, Jacqueline O'Brien, Page C Moore, Rhiannon Dodge, Rebecca Germino

J Rheumatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics.
Nozima Aripova, Joel M Kremer, Dimitrios A Pappas, George Reed, Bryant R England

Rheumatology (Oxford)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Model to Predict Future Biologic or Targeted Synthetic DMARD Switch at a Subsequent Clinic Visit in Rheumatoid Arthritis.
Laura C Cappelli, George Reed, Dimitrios A Pappas, Joel M Kremer

Rheumatol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes in Patients with Rheumatoid Arthritis After Switching Between Interleukin-6-Receptor Inhibitors and Janus Kinase Inhibitors: Findings from an Observational Study.
Anisha B Dua, Kerri Ford, Stefano Fiore, Dimitrios A Pappas, Jud C Janak

Rheumatol Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA Registry.
Dimitrios A Pappas, Jacqueline O'Brien, Lin Guo, Ying Shan, Joshua F Baker

Arthritis Res Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry.
Anthony Sebba, Clifton O Bingham, Vivian P Bykerk, Stefano Fiore, Kerri Ford, Dimitrios A Pappas

Clin Rheumatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meaningful Improvement and Worsening in Patients Who Do Not Achieve Low Disease Activity and Switch Therapy to a New Biologic or Targeted Disease-Modifying Antirheumatic Drug: Results From the CorEvitas RA Registry.
Jeffrey R Curtis, Stefano Fiore, Kerri Ford, Jud C Janak, Hong Chang, Dimitrios A Pappas

J Clin Rheumatol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of targeted rheumatoid arthritis therapeutics on systemic inflammation and anemia: analysis of data from the CorEvitas RA registry.
Anthony S Padula, Dimitrios A Pappas, Stefano Fiore, Taylor S Blachley, Kerri Ford

Arthritis Res Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time regeneration of a working zeolite monitored X-ray diffraction and crystallographic imaging: how coke flees the MFI framework.
Georgios N Kalantzopoulos, Daniel Rojo Gama, Dimitrios K Pappas, Iurii Dovgaliuk, Unni Olsbye

Dalton Trans· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey.
Dimitrios A Pappas, Christine Brittle, Andrew Concoff, Andrew J Holman, Dennis Takasugi

Rheumatol Int· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing predictors of rheumatoid arthritis-associated interstitial lung disease using quantitative lung densitometry.
Michail K Alevizos, Sonye K Danoff, Dimitrios A Pappas, David J Lederer, Cheilonda Johnson

Rheumatology (Oxford)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-step hydrogen production from NH, CH, and biogas in stacked proton ceramic reactors.
Daniel Clark, Harald Malerød-Fjeld, Michael Budd, Irene Yuste-Tirados, Dustin Beeaff, Dimitrios K Pappas

Science· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dr. Kremer et al reply.
Joel M Kremer, George Reed, Dimitrios A Pappas, Kevin Kane, Vivi L Feathers

J Rheumatol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNFi Cycling Versus Changing Mechanism of Action in TNFi-Experienced Patients: Result of the Corrona CERTAIN Comparative Effectiveness Study.
Jeffrey R Curtis, Joel M Kremer, George Reed, Ani K John, Dimitrios A Pappas

ACR Open Rheumatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis.
Anthony James Ocon, George Reed, Dimitrios A Pappas, Jeffrey R Curtis, Joel M Kremer

Ann Rheum Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study.
Stanley Cohen, Alvin F Wells, Jeffrey R Curtis, Rajat Dhar, Theodore Mellors, Dimitrios A Pappas

Rheumatol Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Baseline Anti-cyclic Citrullinated Peptide Antibodies and 6-Month Clinical Response Following Abatacept or TNF Inhibitor Treatment: A Real-World Analysis of Biologic-Experienced Patients with RA.
Leslie R Harrold, Joshua Bryson, Thomas Lehman, Joe Zhuo, Sheng Gao, Dimitrios A Pappas

Rheumatol Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry.
Joel M Kremer, Clifton O Bingham, Laura C Cappelli, Jeffrey D Greenberg, Ann M Madsen, Dimitrios A Pappas

ACR Open Rheumatol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry.
Dimitrios A Pappas, Taylor Blachley, Jennie H Best, Steve Zlotnick, William G Reiss

Rheumatol Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis